Epithelial-myoepithelial carcinoma of the nasopharynx: cases report and literature review熊文举, Lei Liu, Chenfeng Tan et al.|Frontiers in Oncology|2026Cited by 0
Becotatug vedotin plus pucotenlimab as first-line therapy in patients with recurrent or metastatic nasopharyngeal carcinoma: A phase II clinical trial.Lu Liu, Xiaoyuan Wei, Yi-Xiang Wang et al.|Journal of Clinical Oncology|2026Cited by 0
A randomized, non-comparative, multicenter phase II trial of neoadjuvant becotatug vedotin alone or combined with immune checkpoint inhibitors (penpulimab/ivonescimab) in resectable locally advanced head and neck squamous cell carcinoma.Xiaoyuan Wei, Lu Liu, Zhongzheng Xiang et al.|Journal of Clinical Oncology|2026Cited by 0
Digital Phenotyping of Physical Activity and Mortality in Cancer SurvivorsYuanyou Li, Lingjie Fan, Junhan Zhao et al.|MedComm – Future Medicine|2026Cited by 0